TM4SF5 and hepatocellular carcinoma: Here TSIs could act as NK cell immune-checkpoint inhibitors targeting the TM4SF5/SLAMF7 axis, which is highly expressed in HCC.60 The inverse linkage between TM4SF5 and SLAMF7 appears valid in the highly TM4SF5-expressing HCC group.